Plaquenil and Vancomycin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Plaquenil (hydroxychloroquine sulfate) and Vancomycin (vancomycin). Common drug interactions include synovitis among females and double stranded dna antibody positive among males.

The phase IV clinical study analyzes what interactions people have when they take Plaquenil and Vancomycin. It is created by eHealthMe based on reports of 64 people who take the same drugs from the FDA, and is updated regularly.

What is Plaquenil?

Plaquenil has active ingredients of hydroxychloroquine sulfate. It is often used in systemic lupus erythematosus. eHealthMe is studying from 91,019 Plaquenil users. Check the latest studies of Plaquenil.

What is Vancomycin?

Vancomycin has active ingredients of vancomycin. eHealthMe is studying from 17,165 Vancomycin users. Check the latest studies of Vancomycin.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

64 people who take Plaquenil and Vancomycin together, and have interactions are studied.

Plaquenil and Vancomycin drug interactions.

What are the common drug interactions of Plaquenil and Vancomycin, by gender? *:

female:

  1. Synovitis (inflammation of the synovial membrane)
  2. Bone erosion
  3. Tooth disorder (tooth disease)
  4. Pain in extremity
  5. Arthralgia (joint pain)
  6. Body temperature decreased
  7. Cough
  8. Fatigue (feeling of tiredness)
  9. Musculoskeletal disorder (disease of the body's muscles, joints, tendons, ligaments and nerves)
  10. Chest pain

male:

  1. Double stranded dna antibody positive
  2. Haemoglobin decreased
  3. Foetal growth restriction (poor growth of a baby while in the mother's womb during pregnancy)
  4. Hepatitis acute
  5. Low birth weight baby
  6. Maternal exposure before pregnancy (use of substance before pregnancy)
  7. Maternal exposure during pregnancy (use of substance during pregnancy)
  8. Muscle spasticity (tight or stiff muscles and an inability to control those muscles)
  9. Premature baby
  10. Small for dates baby (an unborn baby is growing more slowly and is smaller than most babies are at the same age)

What are the common drug interactions of Plaquenil and Vancomycin, by age (0-1 to 60+)? *:

0-1:

  1. Foetal growth restriction (poor growth of a baby while in the mother's womb during pregnancy)
  2. Low birth weight baby
  3. Maternal exposure before pregnancy (use of substance before pregnancy)
  4. Maternal exposure during pregnancy (use of substance during pregnancy)
  5. Muscle spasticity (tight or stiff muscles and an inability to control those muscles)
  6. Premature baby
  7. Small for dates baby (an unborn baby is growing more slowly and is smaller than most babies are at the same age)
  8. Developmental delay

2-9:

n/a

10-19:

n/a

20-29:

  1. Double stranded dna antibody positive
  2. Haemoglobin decreased
  3. Headache (pain in head)
  4. Pyrexia (fever)
  5. Rash
  6. Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
  7. White blood cell count decreased
  8. Protein urine
  9. Cough
  10. Therapeutic response decreased (less preventive response)

30-39:

  1. Blood sodium decreased
  2. Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
  3. Chest pain
  4. Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
  5. Dyspnoea (difficult or laboured respiration)
  6. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  7. Headache (pain in head)
  8. Influenza
  9. Infusion site bruising
  10. Infusion site haemorrhage (bleeding from infusion site)

40-49:

  1. Hepatitis acute
  2. Abscess limb (limb infection)
  3. Cellulitis (infection under the skin)
  4. Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
  5. Nerve injury
  6. Pain
  7. Perirectal abscess
  8. Rectal abscess (pus in rectum)
  9. Scar
  10. Sepsis (a severe blood infection that can lead to organ failure and death)

50-59:

  1. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  2. Aspartate aminotransferase increased
  3. Asthenia (weakness)
  4. Asthma
  5. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  6. Blood parathyroid hormone decreased
  7. Blood pressure decreased
  8. Body temperature decreased
  9. Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
  10. C-reactive protein increased

60+:

  1. Infusion related reaction
  2. Blood pressure increased
  3. Depression
  4. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
  5. Endometrial disorder
  6. Enterococcus test positive
  7. Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
  8. Gamma-glutamyltransferase increased
  9. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  10. Heart rate increased

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 32 people, 50.00%
  2. Enterococcal Infection: 26 people, 40.62%
  3. Generalised Oedema (swelling all over the body): 25 people, 39.06%
  4. Pain: 7 people, 10.94%
  5. Sleep Disorder: 4 people, 6.25%
  6. Nausea (feeling of having an urge to vomit): 4 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Plaquenil and Vancomycin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Plaquenil and Vancomycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Plaquenil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Vancomycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Plaquenil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vancomycin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on hydroxychloroquine sulfate and vancomycin (the active ingredients of Plaquenil and Vancomycin, respectively), and Plaquenil and Vancomycin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: